The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Skibsted Russell since 2011.
The trader's CIK number is 1308105.
At the time of the last reporting, Skibsted Russell was the Chief Financial Officer of Lineage Cell Therapeutics, Inc.. (stock ticker symbol LCTX).
Also see all insider trading activities at Lineage Cell Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | BTX | 0 | $0 | 0 | $0 | 33,750 | $0 |
| 2017 | BTX | 2,000 | $5,284 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | AOLS | 7,027 | $1,679 | 0 | $0 | 0 | $0 |
| 2011 | AOLS | 20,000 | $8,400 | 0 | $0 | 0 | $0 |
1. Lineage Cell Therapeutics, Inc. (BTX)
2. Aeolus Pharmaceuticals, Inc. (AOLS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-18 | BTX | Option Ex | 22,500 | .00 | 0 |
| 2018-10-04 | BTX | Option Ex | 11,250 | .00 | 0 |
| 2017-08-23 | BTX | Buy | 2,000 | 2.64 | 5,284 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-05-23 | AOLS | Buy | 7,027 | .24 | 1,679 |
| 2011-05-18 | AOLS | Buy | 20,000 | .42 | 8,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Skibsted Russell (Chief Financial Officer of Lineage Cell Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.